Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
The Journal of ECT|June 29, 2011
Iodine-123 fluoropropyl-carbomethoxy-3-β-(4-iodophenyltropane) single-photon emission computed tomography findings before and after electroconvulsive therapy in major depressive disorder with ParkinsonismEric Bui, Julien Delrieu, Thomas Wagner, et al.
Journal of the American Medical Directors Association|August 12, 2017
RETRACTED: Association Between Frailty and Cognitive Impairment: Cross-Sectional Data From Toulouse Frailty Day HospitalBertrand Fougère, Matthieu Daumas, Matthieu Lilamand, et al.
Alzheimer'S & Dementia (New York, N. Y.)|May 12, 2025
The relationship between neurofilament light chain and depressive symptoms according to cognitive statusFederico Bellelli, Jeremy Raffin, Davide Angioni, et al.
The Journal of Prevention of Alzheimer'S Disease|February 26, 2025
Lecanemab for early Alzheimer's disease: Appropriate use recommendations from the French federation of memory clinicsNicolas Villain, Vincent Planche, Matthieu Lilamand, et al.
Alzheimer'S Research & Therapy|October 20, 2020
The impact of a multi-domain intervention on cerebral glucose metabolism: analysis from the randomized ancillary FDG PET MAPT trialJulien Delrieu, Thierry Voisin, Laure Saint-Aubert, et al.
Journal of Neurology|January 29, 2019
Cognitive changes of older adults with an equivocal amyloid loadKristell Pothier, Laure Saint-Aubert, Claudie Hooper, et al.
Journal of Alzheimer'S Disease : JAD|October 7, 2017
Memory Complaints and Cognitive Decline: Data from the GUIDAGE Study1Sophie Dardenne, Julien Delrieu, Sandrine Sourdet, et al.
Alzheimer'S Research & Therapy|October 23, 2023
Cognitive impact of multidomain intervention and omega 3 according to blood Aβ42/40 ratio: a subgroup analysis from the randomized MAPT trialJulien Delrieu, Bruno Vellas, Sophie Guyonnet, et al.
Journal of Alzheimer'S Disease : JAD|May 26, 2019
Neuropsychiatric Symptoms and Risk of Progression to Alzheimer's Disease Among Mild Cognitive Impairment SubjectsSimon Dietlin, Maria Soto, Vera Kiyasova, et al.
Alzheimer'S Research & Therapy|February 4, 2026
Are pre-frail and frail amyloid positive individuals eligible to Lecanemab? A cross-sectional analysis from the Cogfrail real-world cohortFederico Bellelli, Julien Delrieu, Gabor Abellan van Kan, et al.
Pageof 6